Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2015 | 02-2015 | 11-2014 | 08-2014 | 05-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,863 | 1,118 | 6,672 | 1,778 | 2,536 |
| Marketable Securities | 13,307 | 17,046 | 17,714 | 19,528 | 13,069 |
| Receivables | 33 | 2 | 27 | 408 | 268 |
| TOTAL | $17,303 | $18,295 | $24,533 | $21,778 | $15,970 |
| Non-Current Assets | |||||
| PPE Net | 12 | 13 | 15 | 14 | 14 |
| Investments And Advances | 4,806 | 4,665 | 5 | 3 | 6,508 |
| Other Non-Current Assets | 8 | 7 | 7 | 7 | 7 |
| TOTAL | $4,826 | $4,685 | $27 | $24 | $6,529 |
| Total Assets | $22,129 | $22,980 | $24,560 | $21,802 | $22,498 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 765 | 605 | 827 | 973 | 495 |
| TOTAL | $765 | $605 | $827 | $973 | $495 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 37 | 36 | 36 | 36 | 32 |
| TOTAL | $37 | $36 | $36 | $36 | $32 |
| Total Liabilities | $802 | $641 | $863 | $1,009 | $527 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,551 | 10,824 | 10,833 | N/A | 9,956 |
| Common Shares | 129 | 129 | 129 | 121 | 120 |
| Retained earnings | -32,936 | -31,353 | -29,716 | -27,820 | -26,191 |
| Other shareholders' equity | 163 | 100 | 93 | 452 | 468 |
| TOTAL | $21,327 | $22,339 | $23,697 | $20,793 | $21,971 |
| Total Liabilities And Equity | $22,129 | $22,980 | $24,560 | $21,802 | $22,498 |